신천지게임랜드 60.ryn949.top 바로가기 야마토2, 인터넷야마토

바다신2 다운로드용의 눈 게임바다이야기 꽁머니바다이야기주소

야마토3게임다운로드후기 12.ryn949.top 해물어

안전 슬롯사이트 93.ryn949.top 릴게임 종류

야마토게임하기 0.ryn949.top 슬롯 확률

바다이야기조작 59.ryn949.top 릴게임환수율

바다이야기시즌5 29.ryn949.top 무료충전릴게임

오션파라다이스 22.ryn949.top 바다이야기 먹튀 돈 받기

오락실게임 54.ryn949.top 카카오 야마토 먹튀

릴게임한국 37.ryn949.top 안전 검증 릴게임

체리마스터 어플 14.ryn949.top 파칭코종류

바다이야기 기계 가격 54.ryn949.top 야마토5게임다운로드

바로가기 go !! 바로가기 go !!

손오공릴게임다운로드 오션파라다이스게임하는법 해물어 알라딘오락실 야마토온라인주소 릴게임주소 손오공게임 릴게임 손오공 릴게임환수율 황금성포커 오션파라다이스 릴게임 정보 야마토하는곳 파칭코 무료 슬롯 머신 다운 받기 손오공 게임 모바일 게임 공략 황금성 다운로드 온라인 야마토 게임 파칭코게임다운로드 오션파라다이스게임 강원랜드 슬롯머신 규칙 골드몽 먹튀 하이로우하는법 백경게임하는곳주소 바다이야기예시종료 바다이야기 오션파라 다이스게임 하는법 프라그마틱환수율 야마토게임하기 온라인 슬롯 하는 법 온라인신천지게임 없습니다. 슬롯머신 잭팟 안전 슬롯사이트 체리게임주소 오션파라다이스게임하는법 호게임 릴신천지 바다이야기꽁머니 바다이야기 꽁머니 환전 바다이야기시즌7 무료백경 사이다쿨게임 손오공 온라인 게임 예시 릴게임 추천 사이트 온라인야마토주소 프라그마틱 슬롯 조작 황금성 오리지날 양귀비 오리 지날 바다 신천기릴게임 황금성후기 슬롯버프 창공릴게임 오션파라 다이스하는방법 손오공릴게임다운로드 바다이야기 게임방법 릴게임갓 릴게임 사이트 도메인 황금성먹튀 꽁머니사이트 뽀빠이놀이터릴게임 무료충전게임 오션파다라이스 다운로드 프라 그마 틱 무료체험 머니 파칭코 무료슬롯머신 바다이야기파일 신규 릴게임 야마토 무료 게임 알라딘게임다운 프라그마틱 무료게임 모바일릴게임 접속하기 게임바둑이추천 양귀비 바다이야기황금고래 황금성 게임랜드 황금포커성 체리게임바둑이 핸드폰바다이야기 파칭코슬롯 바다신게임 프라그마틱환수율 야마토다운로드 릴게임릴게임갓 오공슬롯 황금성3게임연타 야마토릴게임 바다이야기 게임 다운로드 키지노릴게임 바다이야기기계 야마토2다운로드 야마토5게임 기 무료신천지게임 성인오락황금성 바다이야기 게임장 스위피릴게임 우주전함야마토먹튀 오션파라다이스7하는곳 알라딘게임랜드 무료게임 릴게임추천사이트 바다신2 게임 백경 게임 바다이야기노무현 야먀토5 온라인야마토2 하이클래스릴게임 손오공 게임 다운 릴게임5만 슬롯머신 프로그램 백경다운로드 바다이야기꽁머니환전 슬롯종류 일본 파칭코 오락실게임 파라다이스 슬롯머신 프로그램 바다이야기 꽁 머니 환전 야마토게임사이트 바다이야기 꽁머니 환전 윈윈 알라딘릴게임장 매장판 바다신게임 [Vilnius (Lithuania) = Lim Jeong-yeo, Edaily Reporter] Lithuania, located in the very center of Europe, is actively seeking biotechnology collaboration with South Korea. Partnerships so far have largely been at the academic level, but going forward more business opportunities could arise in biologics manufacturing and novel drug development, said Jekaterina Kaliniene, Head of the Biotechnology Dep 시장경영진흥원연봉 artment at Innovation Agency Lithuania, in a recent interview with Edaily.
Sitting at a cafe in the beautiful Old Town of Vilnius, Kaliniene said, “Lithuanians are ‘hungry’ for market recogn 국가신용보증 ition. To this end, we overdeliver; we’re agile and punctual. Many of our global partners say they are pleasantly surprised by Lithuanian companies’ work quality and attitude.”


공모주
Jekaterina Kaliniene, Head of the BioTech Lab Department(Photo=Lim Jeong-yeo, Edaily)



Lithuania as an efficient and proactive Europ 국제무역사고사장 ean hub

Established in April 2022, Innovation Agency Lithuania is a nonprofit agency under the Lithuanian Ministry of Economy and Innovation. For overseas companies wishing to ent 벤처인 er Lithuania, the agency is the first point of contact. True to its name, the agency fosters innovation, providing consulting and funding from the startup phase of tech companies through their growth and maturity.
“Our goal is to double our GDP from life sciences by 2030. This is why we allocate 1% of our GDP to fostering relevant entrepreneurs and companies,” said Kaliniene, explaining the 774 million euros of investment made in a year.
Innovation Agency Lithuania is headquartered in Vilnius, with shared office spaces in 13 cities across Lithuania, enabling balanced regional development.
Kaliniene explained that Korean companies could engage in various activities in Lithuania, including technology collaboration with local biotech firms, clinical trials, contract manufacturing, and establishing a hub for entry into the European market.
She emphasized, “Lithuania can serve as a gateway to Europe. Once you are certified in Lithuania, you can access all 27 EU member states.”
Kaliniene highlighted Lithuania’s unique strengths as agility and punctuality. “There is a saying in Lithuania that you are just two steps away from knowing the President,” she said. “Being a small country, everyone is well connected, which makes it easier to seek help for swift problem-solving.”
This also applies to local clinical trials: provided the documents are in order, it takes only 60 days from submission to approval. Global pharmaceutical companies such as Eli Lilly, MSD, Novo Nordisk, Pfizer, Roche, and Novartis are all conducting clinical trials in Lithuania.



Lithuania‘s Presidential office(right) sits next to Vilnius University(left)(Photo=Lim Jeong-yeo, Edaily)



Manufacturing, Personalized Medicine, and AI Diagnostics

According to Kaliniene, Lithuania’s major focus areas in life sciences include drug manufacturing, gene editing, artificial intelligence (AI), and diagnostics.
“Lithuania’s life science capacity didn’t emerge overnight,” she explained. “Our differentiated expertise in enzyme production was recognized long ago, which is why Teva and Thermo Fisher Scientific acquired Sicor Biotech (2004) and Fermentas (2010), respectively.”
Currently, the most prominent domestic contract development and manufacturing organization (CDMO) is Northway Biotech. The company has capabilities in producing protein-based biologics as well as gene therapies such as viral vectors and plasmid DNA, and it is expanding its facilities.
Personalized medicine is also an area where Lithuania’s gene-editing technology is gaining attention. In 2012, Virginijus Siksnys, a biochemist and professor at Vilnius University, pioneered CRISPR-Cas9 gene-editing technology. This could well have been Lithuania’s first Nobel Prize, but the 2020 Nobel Prize in Chemistry went to researchers at UC Berkeley and the Max Planck Institute. Professor Siksnys’ breakthrough remains the pride of Lithuania, however, and Kaliniene said, “Siksnys’ work has led to CasZyme, a highly value-adding company developing new gene therapy drugs.”
She further noted, “Lithuania is making significant strategic infrastructure investments to advance life sciences. BioCity, for example, is a private-sector development project valued at $7 billion.”
임정요 (kaylalim@edaily.co.kr)